JUL 21, 2020 11:42 AM PDT

Investigating New Anti-Blood Clotting Treatments

WRITTEN BY: Jasper Cantrell

When it comes to your cardiovascular health, it is important to look at more than just your heart. The cardiovascular system could be summarized as a pathway for your blood to run through your body. Any issues with the proper flow of blood can cause major damage to the body. These issues can be things such as heart dysfunction, obstruction of a blood vessel, or (the scariest, in my opinion) blood clots.

Blood clots form when there is an injury to the blood vessels. The body responds by combining platelets with fibrin at the wound, where they coagulate and prevent blood loss. However, abnormal blood clots can block blood flow and cause tissue damage. 

Several things can be done to prevent blood clots, from exercising to a healthy diet, but some factors are out of your control. Scientists have sought to identify any biomarkers against the risk of blood clots and have found a few with promise.

The Von Willebrand factor (VWF) is one such biomarker.  It is a small protein involved in the initial blood clot formation caused by high shearing forces. These shearing forces are usually due to high blood flow surrounding clogged arteries. It is already considered a poor prognostic indicator for cardiovascular health, and anti-VWF drugs have some promise for blood clot treatment and prevention. 

A team from the Medical University of Vienna in Austria sought to test a new anti-VWF drug, BT200. They set up blood clotting experiments using endotoxin (the toxic part of bacteria) and desmopressin (a kidney drug) to activate VWF. They would then treat the blood with BT200 and observe how it affected VWF activity.

BT200 treatment managed to inhibit VWF activation in all cases. The most significant find was that effective BT200 dosage was tied to VWF levels. This gives critical dosage information for future studies, and retroactive analysis showed that this characteristic was shared amongst all VWF inhibitors. Conventional clotting inhibitors usually do not catch VWF dependent clotting, so more research is needed into this treatment pathway.

The team concludes, “Even under conditions of stimulated VWF release, BT200 potently inhibits VWF activity and VWF-dependent platelet function. This is in contrast to conventional platelet inhibitors whose effects are compromised by elevated VWF under high shear rates.”

Sources: Nature Scientific Reports, LearnBlood

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
SEP 15, 2020
Cardiology
Dopamine Could Cause Heart Arrhythmia After Heart Failure
SEP 15, 2020
Dopamine Could Cause Heart Arrhythmia After Heart Failure
Everyone knows that friend with a tattoo of a molecule of dopamine. Usually associated with the pleasure response, it is ...
SEP 28, 2020
Cardiology
A Single-Cell Atlas Provides New Details on the Heart
SEP 28, 2020
A Single-Cell Atlas Provides New Details on the Heart
For the first time, researchers have gained unprecedented insight into the function of the healthy human heart by creati ...
OCT 08, 2020
Cardiology
Omega-3 Enriched Chicken as a Fish Alternative for Omega-3 Fatty Acids
OCT 08, 2020
Omega-3 Enriched Chicken as a Fish Alternative for Omega-3 Fatty Acids
We have all seen those articles telling us to get more omega-3 fatty acids in our diet. Many studies point to these spec ...
NOV 14, 2020
Cardiology
Chili Peppers May Help Us Live Longer
NOV 14, 2020
Chili Peppers May Help Us Live Longer
Researchers presented preliminary data at the American Heart Association's Scientific Sessions 2020 that suggested t ...
NOV 19, 2020
Cardiology
Examining a Possible Link Between Atherosclerosis and Inflammation
NOV 19, 2020
Examining a Possible Link Between Atherosclerosis and Inflammation
The immune system’s primary duty is to protect the body from dangerous invaders. Many don’t know that it als ...
NOV 22, 2020
Genetics & Genomics
Many Kids with Inherited High Cholesterol Don't Get the Treatment They Need
NOV 22, 2020
Many Kids with Inherited High Cholesterol Don't Get the Treatment They Need
Our bodies need cholesterol for certain crucial functions; it's a vital component of cell walls, for example. But there ...
Loading Comments...